Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Work In Process (2019 - 2022)

Marimed (MRMD) has disclosed Work In Process for 4 consecutive years, with $4.1 million as the latest value for Q1 2022.

  • On a quarterly basis, Work In Process rose 857.98% to $4.1 million in Q1 2022 year-over-year; TTM through Mar 2022 was $4.1 million, a 857.98% increase, with the full-year FY2021 number at $4.7 million, up 895.14% from a year prior.
  • Work In Process was $4.1 million for Q1 2022 at Marimed, down from $4.7 million in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $4.7 million in Q4 2021 to a low of $80476.0 in Q4 2019.
  • A 4-year average of $1.9 million and a median of $468377.0 in 2020 define the central range for Work In Process.
  • Peak YoY movement for Work In Process: surged 482.01% in 2020, then soared 895.14% in 2021.
  • Marimed's Work In Process stood at $80476.0 in 2019, then soared by 482.01% to $468377.0 in 2020, then skyrocketed by 895.14% to $4.7 million in 2021, then fell by 12.77% to $4.1 million in 2022.
  • Per Business Quant, the three most recent readings for MRMD's Work In Process are $4.1 million (Q1 2022), $4.7 million (Q4 2021), and $3.4 million (Q3 2021).